sang ho choi | Medicine and Health Sciences | Best Researcher Award

sang ho choi | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr sang ho choi, Kwangwoon University, South Korea

Assist. Prof. Dr. Sang Ho Choi is an expert in biomedical engineering and artificial intelligence, currently serving as an Assistant Professor at Kwangwoon University, Seoul, Korea ๐Ÿ‡ฐ๐Ÿ‡ท. He leads the Healthcare & AI Lab ๐Ÿง ๐Ÿค–. Previously, he worked as a Staff Engineer at Samsung Research ๐Ÿ“ฑ. Dr. Choi earned his Ph.D. in Biomedical Engineering from Seoul National University ๐ŸŽ“, focusing on sleep monitoring using deep neural networks ๐Ÿ˜ด๐Ÿ”. His research interests include biomedical signal processing, AI for healthcare, and IoT systems ๐ŸŒ. He has published extensively on sleep engineering, neural networks, and health monitoring technologies ๐Ÿ“Š๐Ÿ“š.

Publication Profile

Orcid

Education

Assist. Prof. Dr. Sang Ho Choi is a skilled academic with a Ph.D. in Biomedical Engineering from Seoul National University (2014โ€“2020), where he specialized in unconstrained sleep monitoring and modulation using deep neural networks and closed-loop stimulation. He conducted his research under the guidance of Prof. Kwang Suk Park. Prior to this, he earned a B.S. in Bio-mechatronic Engineering, with a double major in Electronic and Electrical Engineering, from Sungkyunkwan University (2009โ€“2014). He was mentored by Prof. Chang Hyun Choi and Prof. Jitae Shin. His work integrates bioengineering and innovative neural network technologies. ๐Ÿง ๐Ÿ’ป๐ŸŽ“

Experience

The research initiatives include groundbreaking work in neuro-chip design and neuro-computing platforms, simulating the human nervous system, funded by the Ministry of Science and ICT (MSIT) Korea (Jul 2022 – Dec 2029) as Co-PI. Another project focuses on intelligent biomedical wireless power transfer, under the National Research Foundation of Korea (NRF) (Mar 2022 – Feb 2024), also as Co-PI. Additionally, the development of AI-based vital signal and sleep monitoring technology using UWB radar is being led as PI (Jul 2021 – Feb 2023) by the NRF. These innovative efforts aim to revolutionize healthcare technology. ๐Ÿง ๐Ÿ’ก๐Ÿ“ก๐Ÿค–

Research Interest

Assist. Prof. Dr. Sang Ho Choi specializes in biomedical signal processing and analysis, with a strong focus on Artificial Intelligence (AI) applications for biomedical engineering and deep learning. His research spans areas like sleep engineering, healthcare systems, and the integration of Internet of Things (IoT) systems to enhance healthcare outcomes. By leveraging advanced AI techniques, Dr. Choi explores innovative solutions for improving diagnostics, treatment processes, and patient care efficiency. His work aims to merge technology with healthcare, contributing significantly to the future of smart, data-driven medical systems. ๐Ÿง ๐Ÿ’ก๐Ÿฉบ๐Ÿค–๐Ÿ’ป

Ongoing Projects

Assist. Prof. Dr. Sang Ho Choi is a Co-PI on significant national projects funded by Korea’s MSIT and NRF, leading innovative research in the fields of neuro-chip design and AI-driven health monitoring technologies. His work is shaping the future of healthcare by integrating advanced neurotechnology with artificial intelligence. With a passion for cutting-edge scientific advancements, Dr. Choi’s contributions are paving the way for transformative breakthroughs in medical devices and digital health. His dedication to improving healthcare through technological innovation continues to inspire and drive progress in the industry. ๐Ÿง ๐Ÿ’ก๐Ÿค–๐Ÿ’Š๐Ÿ”ฌ

Research Focus

Assist. Prof. Dr. Sang Ho Choi’s research primarily focuses on biomedical signal processing and health monitoring using advanced sensor technologies. His work includes exploring wearable devices for sleep monitoring, studying the functional connectivity of the amygdala in chronic insomnia patients, and utilizing spiking neural networks for analyzing biomedical signals. He also investigates real-time detection systems, like apnea-hypopnea event detection using radar sensors, and continues to push the boundaries of sensor-based health technologies. His contributions extend to neuroengineering and biomedical engineering, aiming to enhance the accuracy and efficiency of health monitoring systems. ๐Ÿง ๐Ÿ“ก๐Ÿ’ก๐Ÿ’ค๐Ÿ‘ฉโ€โš•๏ธ

Publication Top Notes

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Dr Federico Bozzetti, ASLC, Italy

Dr. Federico Bozzetti is an esteemed Italian physician and specialist in oncology and surgery, born in Milan, Italy. He completed his studies at the University of Milan, University of Florence, and University of Pavia, followed by specialized training at renowned institutions like Lund University and Columbia University. With over 710 publications, including articles on cancer nutrition and home parenteral nutrition, Dr. Bozzetti is a leader in gastrointestinal oncology and artificial nutrition. He has held significant roles in prestigious societies, including as President of ESPEN. His research focuses on cancer treatment, liver transplantation, and cancer-related malnutrition.

Publication Profile

Orcid

Educational Background

Dr. Federico Bozzetti is a distinguished medical professional with multiple specializations in medicine, surgery, oncology, and epidemiology, earned from prestigious institutions such as the University of Milan, University of Pavia, and University of Florence ๐ŸŽ“๐Ÿฅ. Known for his academic excellence, he graduated with cum laude honors and achieved top scores in various examinations ๐ŸŒŸ๐Ÿ“š. Dr. Bozzetti’s vast expertise in medicine and cancer care has significantly impacted the field, reflecting his dedication to both clinical practice and research ๐Ÿ”ฌ๐Ÿ’‰. His contributions continue to shape advancements in healthcare, particularly in oncology and epidemiology ๐ŸŒ๐Ÿ’ช.

Experience

Dr. Federico Bozzetti is a renowned expert in cancer treatment and nutritional support. He has held leadership roles at prestigious institutions, including the Istituto Nazionale per lo Studio e la Cura dei Tumori in Milan. His groundbreaking research and clinical contributions have greatly advanced cancer care, particularly in the areas of nutrition for cancer patients. With a deep commitment to improving patient outcomes, Dr. Bozzetti’s work continues to inspire and shape the future of oncology and supportive care.

Global Influence

Dr. Bozzetti is a highly influential figure in the field of parenteral and enteral nutrition. His active involvement in numerous professional societies showcases his global impact. He is a founder and key member of both the European and Italian Societies of Parenteral and Enteral Nutrition (ESPEN and ISPEN). In addition to his contributions to these societies, Dr. Bozzetti plays a significant role in international collaborations, further advancing the field. He is also an esteemed member of various editorial boards, enhancing the scientific community with his expertise. ๐ŸŒ๐Ÿฝ๏ธ๐Ÿ“š๐Ÿ’ก๐ŸŒฑ

Research Focus

Dr. Federico Bozzetti’s research primarily focuses on clinical nutrition, particularly in the context of cancer patients and those requiring specialized nutrition support. His work explores the role of physical exercise in improving outcomes for advanced cancer patients undergoing systemic therapy, as well as the challenges and outcomes of home enteral nutrition for patients and caregivers. Dr. Bozzetti also revisits the importance of nutrition for malnourished cancer patients, and he contributes to guidelines on home parenteral nutrition. His research seeks to improve patient care through better understanding of nutritional needs and therapy during illness. ๐Ÿฝ๏ธ๐Ÿฅ๐Ÿ’ช๐Ÿ“š

Publication top Notes

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Dr Tracey Young-Sharma, Ministry of Health and Medical Service FIji, Fiji

Dr. Tracey Young-Sharma is an accomplished physician specializing in internal medicine and antimicrobial resistance (AMR). She holds a Masters of Medicine from Fiji National University (2019) and has been awarded the ASID GOLD Medal. Currently an AMR consultant for the World Health Organization, Dr. Young-Sharma has held various roles, including Consultant Physician and Registrar at CWM Hospital. She has contributed to multiple studies on antimicrobial resistance and its impact in Fiji, with notable publications in The Lancet and JGAR. Dr. Young-Sharma is also the Chairperson of the Infection Prevention Control Committee at CWMH. ๐Ÿฅ๐Ÿฆ ๐Ÿ“š๐ŸŒ

Publication Profile

Scopus

Education

Dr. Tracey Young-Sharma is a highly accomplished medical professional with a strong background in Internal Medicine. She completed her Masters of Medicine in Internal Medicine at Fiji National University in 2019. Prior to that, she earned a Postgraduate Diploma in Internal Medicine in 2016 and a Bachelor’s degree in Medicine and Surgery from the Fiji School of Medicine in 2010. Dr. Young-Sharma has been recognized for her excellence in the field, receiving the prestigious Australian Society of Infectious Disease (ASID) GOLD Medal Award ๐Ÿ…๐Ÿ’‰. Her dedication to improving healthcare continues to inspire and impact the medical community. ๐Ÿ‘ฉโ€โš•๏ธ๐ŸŒŸ

Experience

Dr. Tracey Young-Sharma is an AMR consultant for the World Health Organisation (WHO) since August 2024 ๐ŸŒ. Previously, she served as a Consultant Physician at CWM Hospital (2022-2024) ๐Ÿฅ and as a Registrar at the same hospital from 2016 to 2021. Prior to that, she worked as a Registrar in Internal Medicine at Labasa Hospital in 2015 ๐Ÿฉบ. Dr. Young-Sharma began her career as a Medical Officer at Levuka Hospital and Koro Health Centre (2012-2014) ๐Ÿฅ and completed her internship at CWM Hospital in 2011. Her extensive experience spans various medical roles, contributing to healthcare development. ๐Ÿ‘ฉโ€โš•๏ธ๐ŸŒฟ

Professional Membershipsย 

Dr. Tracey Young-Sharma is a dedicated healthcare professional with strong affiliations in the medical field. She is an Associate Member of the Internal Medicine Society of Australia and New Zealand and a member of the Internal Medicine Organisation of the Pacific. Additionally, Dr. Young-Sharma is part of the International Women’s Association, the Fiji Medical Association, and the Australasian College of Infection Prevention and Control. In 2022, she served as the Chairperson of the Infection Prevention and Control Committee at CWMH. Her active roles reflect her commitment to advancing healthcare and fostering collaboration in the medical community. ๐ŸŒ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿ’‰๐Ÿฉบ

Research Focus

Dr. Tracey Young-Sharma’s research primarily focuses on antimicrobial resistance (AMR), particularly in resource-limited settings like Fiji. Her work involves genomic surveillance and epidemiological studies to understand the spread of carbapenem-resistant organisms and other multidrug-resistant pathogens. Dr. Young-Sharma’s studies also emphasize the impact of AMR on healthcare outcomes, including attributable mortality and length of hospital stays. She is also involved in improving healthcare workers’ knowledge and readiness to combat AMR through intervention studies. Her research aims to inform public health strategies and healthcare policies in the context of global AMR challenges. ๐Ÿฆ ๐Ÿ”ฌ๐ŸŒ๐Ÿ‘ฉโ€๐Ÿ”ฌ๐Ÿ’‰

Publication Top Notes

Successful management of a multi-species outbreak of carbapenem-resistant organisms in Fiji: a prospective genomics-enhanced investigation and response

Knowledge, attitudes, and readiness about critical antimicrobial resistant organisms among healthcare workers at colonial war memorial hospital in Fiji: a pre and post intervention study

The epidemiology of enterococci in a tertiary hospital and primary healthcare facilities in Fiji (2019โ€“2022)

The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019โ€“2022

Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji

Epidemiology, antimicrobial resistance and outcomes of Staphylococcus aureus bacteraemia in a tertiary hospital in Fiji: A prospective cohort study

Panagiotis Liakos | Medicine and Health Sciences | Best Researcher Award

Panagiotis Liakos | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Panagiotis Liakos, Faculty of Medicine, University of Thessaly, Greece

Prof. Dr. Panagiotis Liakos is an esteemed biochemist and researcher specializing in cellular biochemistry and hypoxia-related cancer mechanisms. He earned his Maรฎtrise, Masterโ€™s, and Ph.D. in Molecular and Cellular Biology from Joseph Fourier I University, France. His postdoctoral work at Aristotle University in Greece laid the foundation for his academic career, leading him to his current role as Professor and Director of the Department of Basic and Applied Biomedical Sciences at the University of Thessaly. His research focuses on hypoxia-inducible factors (HIFs), particularly HIF-2ฮฑ, exploring its role in cancer and angiogenesis. ๐Ÿงฌ๐Ÿ‘จโ€๐Ÿ”ฌ๐Ÿ“š

Publication Profile

google scholar

Educationย 

Prof. Dr. Panagiotis Liakos is a distinguished biochemist with a career spanning from Grenoble to Greece. He completed a Maรฎtrise in Biochemistry (1994) and a Masterโ€™s in Molecular and Cellular Biology (1995) at Joseph Fourier I University, France, followed by a PhD (1999) in Biochemistry and Cellular Endocrine Regulation. His postdoctoral research was conducted at Aristotle University Thessaloniki. In 2003, he became a Lecturer at the University of Thessaly, advancing to Professor in 2022. Currently, he leads the Department of Basic and Applied Biomedical Sciences. His clinical expertise includes years at Larissa University Hospital. ๐ŸŒ๐Ÿ”ฌ๐Ÿ“š๐Ÿ‘จโ€๐Ÿ”ฌ๐Ÿ’ผ

Research Project

Prof. Dr. Panagiotis Liakos has significantly contributed to pioneering health research. Highlights include leading the French Ministry of Healthโ€™s 1994 Breast Cancer Prevention program, advancing studies on ACTH receptor expression in adrenal glands (1995-1998), and collaborating on a French-Portuguese program to analyze steroidogenic enzymes in rats and adrenal carcinomas. Furthering adrenal cancer research, he partnered with the Fondation pour la Recherche Mรฉdicale (1998-1999). Dr. Liakos explored metalloproteases in skin pathophysiology in a Greek program (2001-2003) and obesity rates in Thessaly (2005-06). His work on signaling pathways under hypoxic stress enriches endocrine research. ๐Ÿงฌ๐Ÿ”ฌ

Experience

Prof. Dr. Panagiotis Liakos has been a dedicated educator and coordinator in molecular biology, genetics, and biochemistry since 2001. He taught Biochemistry I & II and Clinical Biochemistry at Democritus University of Thrace, later joining the University of Thessaly to instruct Molecular Biology, Metabolism Regulation, and various biochemistry courses. Since 2004, he has led the Clinical Biochemistry course for medical students and coordinated the Cellular Signaling course in molecular medicine. His teaching repertoire includes postgraduate courses on reproduction genetics, human genetics, and balanced nutrition. Prof. Liakosโ€™s commitment to education spans two decades, fostering expertise in health sciences. ๐Ÿ“˜๐Ÿงฌ๐Ÿ‘จโ€๐Ÿซโœจ

Honors

Prof. Dr. Panagiotis Liakos has been recognized internationally for his research achievements, receiving prestigious scholarships and fellowships from the French Ministry of Research and Fondation pour la Recherche Mรฉdicale. These honors underscore his dedication and impactful contributions to his field, highlighting the global relevance of his work. Through these awards, Dr. Liakos has advanced his research, fostering significant progress and collaboration. His achievements not only emphasize his scientific expertise but also reflect his commitment to excellence in research and innovation. ๐ŸŒ๐Ÿ“š๐Ÿ”ฌ

Research Focus

Prof. Dr. Panagiotis Liakos specializes in cellular and molecular biology, particularly focusing on hypoxia and its effects on cellular processes. His research explores how hypoxia-inducible factors (HIFs), especially HIF-1 and HIF-2, regulate gene expression under low-oxygen conditions and influence cancer progression, lipid metabolism, and viral replication. Dr. Liakosโ€™s work also examines the effects of oxidative stress and signaling pathways like PI-3K and MAPK on cellular adaptation to hypoxic stress. His contributions are significant in understanding hypoxia’s role in disease states such as cancer and liver disease, and its broader implications for therapeutic development. ๐Ÿงฌ๐Ÿฉบ๐Ÿ”ฌ๐ŸŒฌ๏ธ๐Ÿ“Š

Publication Top Notes

Hypoxia causes triglyceride accumulation by HIF-1-mediated stimulation of lipin 1 expression

Cobalt induces hypoxia-inducible factor-1ฮฑ (HIF-1ฮฑ) in HeLa cells by an iron-independent, but ROS-, PI-3K-and MAPK-dependent mechanism

Bortezomib represses HIF-1ฮฑ protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells

The role of hypoxiaโ€inducible factorโ€2 alpha in angiogenesis

Cushingโ€™s syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis

Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells

 

Antoinette Oot | Medicine and Health Sciences | Best Researcher Award

Antoinette Oot | Medicine and Health Sciences | Best Researcher Award

Dr Antoinette Oot, NYU / NYC HHC Bellevue, United States

Based on the information provided, Antoinette Oot, MD, MPH, appears to be a strong candidate for a Best Researcher Award.

Publication profile

Scopus

Education

Antoinette Oot, MD, MPH, has a robust educational background that spans several prestigious institutions. She is currently a Fellow in Complex Family Planning at New York University/NYC Health + Hospitals Bellevue, a role she has held since July 2024. Previously, she served as the Administrative Chief Resident in the Department of Obstetrics and Gynecology at the same institution from 2020 to 2024. Dr. Oot earned her M.D./M.P.H. with honors from Northwestern University, Feinberg School of Medicine in 2020, and holds a B.Sc. in Chemistry with Honors from Brown University. Her early academic journey began at New York University, where she studied biochemistry. This educational trajectory demonstrates her commitment to both clinical excellence and public health, making her a strong candidate for the Best Researcher Award.

Work Experience & Post-Graduate Learning

Dr. Oot has accumulated significant work experience and engaged in continuous post-graduate learning, particularly in leadership and educational roles. As the Administrative Chief Resident at NYU, she optimized personnel coverage, facilitated communication, and promoted a fair work environment. She also served as the Resident OB/Gyn Clerkship Advisor, providing mentorship and improving medical education. Additionally, Dr. Oot has been an advocate for resident perspectives as a Class Representative on the Education Committee at NYU Langone Hospitals. Her experience extends to mentoring students and contributing to curricular development at Northwestern University. These roles highlight her dedication to improving medical education and her leadership skills, reinforcing her suitability for the Best Researcher Award.

Honors/Awards

Dr. Oot has received numerous honors and awards throughout her career, reflecting her outstanding contributions to the field of obstetrics and gynecology as well as public health. Notable awards include the 2023 Ryan Program Resident Award for Excellence in Family Planning and the 2022 Resident Recognition Award for Medical Student Education from NYU OB/GYN. She also received the Excellence in Public Health Award from the US Public Health Services in 2020 and was elected to the Gold Humanism Honor Society in 2019. These accolades underscore her exceptional research, clinical skills, and commitment to advancing womenโ€™s health, making her an exemplary candidate for the Best Researcher Award.

Presentations

Dr. Oot has actively participated in academic presentations, sharing her research findings at national conferences. In 2023, she delivered an oral presentation at the American Public Health Association Annual Meeting on increasing HIV pre-exposure prophylaxis among cisgender women. Her poster presentations at the Society of Gynecologic Surgeons and Society of Maternal-Fetal Medicine annual meetings further highlight her research involvement in women’s health and obstetric care. Her ability to present complex medical research to her peers indicates her leadership in the field and further supports her candidacy for the Best Researcher Award.

Publications

Dr. Oot has an impressive list of publications, contributing to various high-impact journals in the fields of obstetrics, gynecology, and public health. Her research spans a range of topics, including maternal morbidity, HIV prevention, and vaginal health, showcasing her broad expertise and commitment to improving patient outcomes. Notably, her recent work includes a mixed-methods evaluation of an HIV pre-exposure prophylaxis educational intervention published in AIDS Care and studies on maternal health in the Journal of Womenโ€™s Health. Her extensive publication record is a testament to her research capabilities, making her a strong candidate for the Best Researcher Award.

Personal Interests

Outside of her professional life, Dr. Oot enjoys baking, needlepoint, embroidery, and attending comics and art festivals. These hobbies provide a well-rounded perspective to her character, balancing her rigorous academic and professional pursuits with creative and relaxing activities. This personal insight into Dr. Ootโ€™s life adds to her overall profile, showing her as a dedicated and multifaceted individual, further strengthening her candidacy for the Best Researcher Award.

Conclusion

Dr. Antoinette Oot’s extensive education, leadership in medical education, significant research contributions, and numerous awards position her as an outstanding candidate for the Best Researcher Award. Her dedication to advancing women’s health and public health, coupled with her personal commitment to mentorship and education, make her a deserving recipient of this recognition.

Research focus

The research focus of this individual centers on women’s health, obstetrics, and gynecology, with a particular emphasis on conditions affecting women such as genitourinary syndrome of menopause, maternal morbidity, and bacterial vaginosis. They also explore healthcare practices and policies, including interventions for HIV prevention and the evaluation of healthcare delivery in obstetric settings. Additionally, they investigate the use of electronic health records for analyzing maternal and neonatal complications, reflecting a commitment to improving health outcomes for women through research and healthcare policy reform. ๐ŸŒธ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿ“Š๐Ÿ’Š

Publication top notes

A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause

A mixed-methods evaluation of an HIV pre-exposure prophylaxis educational intervention for healthcare providers in a NYC safety-net hospital-based obstetrics and gynecology clinic

Association of Antenatal Housing Instability with Perinatal Care Utilization and Outcomes

Vaginal and Extra-Vaginal Bacterial Colonization and Risk for Incident Bacterial Vaginosis in a Population of Women Who Have Sex with Men

Management of Pelvic Organ Prolapse in the Adult Congenital Genitourinary Patient

Trends and Risk Markers for Severe Maternal Morbidity and Other Obstetric Complications

Genetic variation in toll-like receptor 5 and colonization with flagellated bacterial vaginosis-associated bacteria

Using Electronic Health Record and Administrative Data to Analyze Maternal and Neonatal Delivery Complications

Todayโ€™s Students, Tomorrowโ€™s Physicians: Opinions on Enacted and Prospective Health Care Policies

 

 

Rajendra Rohokale | Medicine and Health Sciences | Best Researcher Award

Rajendra Rohokale | Medicine and Health Sciences | Best Researcher Award

Dr Rajendra Rohokale, University of Florida, United States

Dr. Rajendra Rohokale is a Research Scientist at the University of Florida, specializing in Synthetic Organic Chemistry, Carbohydrate Chemistry, and Glycochemistry. With a Ph.D. from Savitribai Phule Pune University, his notable projects include synthesizing complex carbohydrates for therapeutic applications and developing fully synthetic cancer vaccines. Dr. Rohokale’s work has led to significant advancements in glycoimmunology and drug delivery. An experienced researcher and reviewer for prestigious journals, he has over 360 citations on Google Scholar and holds an Orchid ID: orcid.org/0000-0001-8083-0466. ๐ŸŒŸ๐Ÿงช๐Ÿ”ฌ๐Ÿ“š

Publication profile

Orcid

Education

๐ŸŽ“ From 2010 to 2017, Rajendra Rohokale pursued a Ph.D. in Organic Chemistry at the Department of Chemistry, Savitribai Phule Pune University, Pune, India, under the guidance of Prof. Dilip D. Dhavale (F.A.Sc, F.N.A.Sc.). Their thesis was titled “Chiron Approach Towards the Syntheses of Amino Acids, Piperidine, Azepane, Polyhydroxylated Pyrrolizidine Alkaloids and Activation of Diazo-Ketones Using Visible Light Photoredox Catalysis and Dye.” [Name] earned their Master of Science (Organic Chemistry) (First Class) from the same university in 2009 and completed their Bachelor of Science (Chemistry) (First Class with Distinction) from New Arts, Science, and Commerce College, Ahmednagar in 2007. ๐Ÿ“š๐Ÿ”ฌ

Experience

๐Ÿงช Since August 2023, I’ve been a Research Scientist at the University of Florida, Gainesville. From January 2019 to August 2023, I was a Post-doctoral Research Associate at the same institution. My work focuses on synthesizing complex carbohydrates and their conjugates for therapeutic applications, including the development of glycosphingolipids (GSLs) and monophosphoryl lipid-A derivatives as cancer vaccine carriers. I specialize in synthetic organic and carbohydrate chemistry, creating efficient methods for synthesizing oligosaccharides and glycoconjugates. My research aims to advance cancer immunotherapy and glycoimmunology, with significant contributions to medical science. ๐Ÿ’Š๐Ÿงซ๐Ÿ”ฌ

Presentations

He have actively participated in numerous esteemed conferences, including the Florida Heterocyclic Conference 2022 (FloHet 2022) at the University of Florida in March 2022 and the ChemPhotoChem-EJOC joint virtual symposium on Photoreact Catalysis in December 2021. He also attended FloHet 2020 at the University of Florida in March 2020. He presented a talk at the National Conference on “Bioinspired Materials in Science” at New Arts College, Pune, India, in January 2018. Additionally, He participated in the Satellite Meeting on Frontiers in the Chemistry & Biology of Oligosaccharides in January 2014 and attended various other international conferences from 2009 to 2013. ๐ŸŒŸ๐Ÿ”ฌ๐ŸŒ๐Ÿ“š

Research focus

Dr. Rajendra Rohokale’s research focuses on the synthesis and functional analysis of glycosphingolipids (GSLs) and their interactions in cell membranes. His work spans developing bifunctional GSL probes for studying GSL-interacting proteins, creating novel vaccine adjuvants, and exploring bacterial polysaccharide-based antibacterial conjugate vaccines. He also delves into advanced chemical synthesis techniques for GSLs and their derivatives, utilizing methods like diastereoselective cycloaddition and chemoenzymatic synthesis. Dr. Rohokale’s contributions significantly impact medicinal chemistry, organic chemistry, and infectious disease research. ๐Ÿงช๐Ÿ”ฌ๐Ÿ’‰

Publication top notes

Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes

Diastereoselective 1,3-Dipolar Intramolecular Nitrone Olefin Cycloaddition (INOC) Reaction of a Sugar-derived Allyl Alcohol: Synthesis of Functionalized Aminocyclopentitols.

Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants

Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines

Structural characterization and analysis of different epimers of neutral glycosphingolipid LcGg4 by ion mobility spectrometry-mass spectrometry

A Diversity-Oriented Strategy for Chemical Synthesis of Glycosphingolipids: Synthesis of Glycosphingolipid LcGg4 and Its Analogues and Derivatives

Iridium(III)-Catalyzed Alkynylation of 2-(Hetero)arylquinazolin-4-one Scaffolds via Cโ€“H Bond Activation

Eosin y photoredox catalyzed net redox neutral reaction for regiospecific annulation to 3-sulfonylindoles: Via anion oxidation of sodium sulfinate salts

Metal-Free Synthesis of 3-Thiocyanatobenzothiophenes by Eosin Y Photoredox-Catalyzed Cascade Radical Annulation of 2-Alkynylthioanisoles

Visible-Light-Mediated Eosin Y Photoredox-Catalyzed Vicinal Thioamination of Alkynes: Radical Cascade Annulation Strategy for 2-Substituted-3-sulfenylindoles